levofloxacin has been researched along with 5-demethylnobiletin in 1 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (5-demethylnobiletin) | Trials (5-demethylnobiletin) | Recent Studies (post-2010) (5-demethylnobiletin) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 42 | 0 | 33 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y; Chen, J; Han, Y; Liang, X; Song, M; Xiao, H; Xiao, J; Yang, X; Zhan, M; Zhao, C | 1 |
1 other study(ies) available for levofloxacin and 5-demethylnobiletin
| Article | Year |
|---|---|
Dietary 5-demethylnobiletin prevents antibiotic-associated dysbiosis of gut microbiota and damage to the colonic barrier.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Butyric Acid; Cefuroxime; Colon; Dysbiosis; Gastrointestinal Microbiome; Intestinal Diseases; Intestines; Levofloxacin; Mice | 2023 |